0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HK$
0,00%
(0,00) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto0775 tikeri uchun statistika yaratilmoqda...
Ochish
0,51 HK$
Yuqori
0,52 HK$
Past
0,51 HK$
Bozor kapitali
4,90 mlrd
Oʻrtacha hajm
1,66 mln
Hajmi
956,00 ming
52 haftalik eng yuqori
1,02 HK$
52 haftalik eng past
0,51 HK$
Aksiya boʻyicha daromad
-0,01 HK$
Muomaladagi aksiyalar
9,61 mlrd
Xodimlar soni
2 ming
Ochish
0,51 HK$
Yuqori
0,52 HK$
Past
0,51 HK$
Bozor kapitali
4,90 mlrd
Oʻrtacha hajm
1,66 mln
Hajmi
956,00 ming
52 haftalik eng yuqori
1,02 HK$
52 haftalik eng past
0,51 HK$
Aksiya boʻyicha daromad
-0,01 HK$
Muomaladagi aksiyalar
9,61 mlrd
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business Wire
·
34 daqiqa oldin
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
Simply Wall Street
·
51 daqiqa oldin
KLA (KLAC) Stock Is Caught In A Historic Chip Equipment Losing Streak
TradingView
·
55 daqiqa oldin
News by CNBC TV18 on TradingView, 2026-10-18 — cnbctv:f99f7968e094b:0
Bloomberg.com
·
1 soat oldin
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
CK Life Sciences Intl (Holdings) Inc haqida
CEOYing Choi Yu
Xodimlar soni1,92 ming
Asos solingan2000
Bosh ofislar-
Sektor-
Veb-saytck-lifesciences.com